DUX4 and facioscapulohumeral muscular dystrophy: Metabolic dysregulation, associated with DUX4 activity, varies between mild and severe FSHD patients, with mild cases exhibiting compensatory mechanisms to mitigate metabolic stress, inflammation, and oxidative damage.